Launch won't make an impact. Need to see 2 quarters of sales growth before market takes vascucel seriously. All about infusion and Cardiocel. Vax results may warrant further investment to try to improve but it's not worth very much with current results. Helps but it's no cure.
It's going nicely, page-9
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.000(0.00%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $12.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.99 | 719 | 2 |
View Market Depth
| Last trade - 10.00am 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable